John Maris, MD is the Principle Investigator for the Cancer Research Training Program (T32), which prepares the next generation of cancer researchers by providing protected time in an environment dedicated to the enhancement of research skills and concepts. Six post-doctoral trainees, who have completed their training in the clinical aspects of medical oncology, pediatric oncology, radiation oncology or pathology receive two years of research training in contemporary biomedical or clinical investigation under the mentorship of senior scientists. These experienced research mentors are drawn from the CCCR and Cancer Center's Basic Research Programs (Immunology, Virology, Cell and Molecular Biology, Cancer Genetics, Pediatrics) and Clinical Investigations Programs (e.g., Cancer Pharmacology and Experimental Therapeutics; Cancer Epidemiology and Biostatistics).
The training program is specifically designed to select, prepare,and motivate trainees to pursue academic positions in oncology. The integrated curriculum involves formal course work, research seminars and conferences, lecture series, and supervised research projects. Those pursuing clinical research are expected to complete a Master's level curriculum in either Cancer Pharmacology or in Cancer Epidemiology and Biostatistics (including genetic epidemiology, outcomes research or bioethics). An Executive Committee oversees trainee selection and recruitment, the training program, and evaluates individual trainee progress.
The Cancer Center is a long-standing NCI-designated Comprehensive Cancer Center, and is recognized for its interdisciplinary research programs, integration of basic and clinical investigation, and patient care. Fifteen Shared Resources facilitate cancer investigation. Extensive trainee research opportunities spanning all aspects of cancer research are available through the The Children's Hospital of Philadelphia, University of Pennsylvania and its School of Medicine, Wistar Institute, and Veterans' Administration Medical Center, all of which have an outstanding record in cancer research and are located on a single campus.
For additional information and application materials please contact John Simpkins.